12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia
- 1. Advanced Drug Research Laboratories, Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50, Kawagishi, Toda, Saitama 335-8505 (Japan)
- 2. Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, 4259-B-65 Nagatsuta-cho, Midori-ku, Yokohama 226-8501 (Japan)
- 3. School of Life Science and Technology, Tokyo Institute of Technology, 4259-B-65 Nagatsuta-cho, Midori-ku, Yokohama 226-8501 (Japan)
Description
Jasmonates are plant lipid–derived oxylipins that act as key signaling compounds in plant immunity, germination, and development. Although some physiological activities of natural jasmonates in mammalian cells have been investigated, their anti-inflammatory actions in mammalian cells remain unclear. Here, we investigated whether jasmonates protect mouse microglial MG5 cells against lipopolysaccharide (LPS)–induced inflammation. Among the jasmonates tested, only 12-oxo-phytodienoic acid (OPDA) suppressed LPS-induced expression of the typical inflammatory cytokines interleukin-6 and tumor necrosis factor α. In addition, only OPDA reduced LPS-induced nitric oxide production through a decrease in the level of inducible nitric oxide synthase. Further mechanistic studies showed that OPDA suppressed neuroinflammation by inhibiting nuclear factor κB and p38 mitogen-activated protein kinase signaling in LPS-activated MG5 cells. In addition, OPDA induced expression of suppressor of cytokine signaling-1 (SOCS-1), a negative regulator of inflammation, in MG5 cells. Finally, we found that the nuclear factor erythroid 2-related factor 2 signaling cascade induced by OPDA is not involved in the anti-inflammatory effects of OPDA. These results demonstrate that OPDA inhibited LPS-induced cell inflammation in mouse microglial cells via multiple pathways, including suppression of nuclear factor κB, inhibition of p38, and activation of SOCS-1 signaling. -- Highlights: •OPDA attenuates LPS-induced inflammatory cytokines such as IL-6 and TNF-α. •OPDA reduces LPS-induced iNOS expression and NO production. •OPDA suppresses NF-κB and p38 pathways and activates SOCS-1 signaling.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2016.04.060Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2016.04.060;
- PII
- S0006-291X(16)30567-8;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 473
- Journal Issue
- 4
- Journal Page Range
- p. 1288-1294
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 48043411
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- GERMINATION; IMMUNITY; INFLAMMATION; INHIBITION; LIPOPOLYSACCHARIDES; LYMPHOKINES; MICE; NECROSIS; NEOPLASMS; NITRIC OXIDE; RADIOPROTECTIVE SUBSTANCES
- Descriptors DEC
- ANIMALS; CARBOHYDRATES; CHALCOGENIDES; DISEASES; DRUGS; GROWTH FACTORS; LIPIDS; MAMMALS; MITOGENS; NITROGEN COMPOUNDS; NITROGEN OXIDES; ORGANIC COMPOUNDS; OXIDES; OXYGEN COMPOUNDS; PATHOLOGICAL CHANGES; POLYSACCHARIDES; PROTEINS; RESPONSE MODIFYING FACTORS; RODENTS; SACCHARIDES; SYMPTOMS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.